Elaine M. Hylek, MD
Professor
Boston University School of Medicine
Dept of Medicine
General Internal Medicine Section

MD, University of Pittsburgh School of Medicine
MPH, Harvard School of Public Health
MS, University of Pittsburgh



Expertise includes: Arterial Thrombosis; Venous Thrombosis; Atrial Fibrillation; Safety and Effectiveness of Antithrombotic Therapy.

Active Staff Privileges
Boston Medical Center
Medicine



2011-2011 Other: Awarded Best Doctors in America 2007, 2009, 2011


Personnel agreement for research services of Elaine M. Hylek
01/01/2012 - 12/31/2013 (PI)
Department of Veterans Administration, B

Personnel Agreement for Research Services of Elaine Hylek
01/01/2011 - 12/31/2011 (PI)
Department of Veterans Affairs

Phase II Study - Development and Implementation of Clinical Practice Guidelines in a Large Teaching Hospital for the Use of Fragmin as Bridging Therapy
07/01/2005 - 06/30/2007 (PI)
Pfizer, Inc.

Anticoagulation Consortium to Improve Outcomes Nationally (ACTION) Registry
03/01/2005 - 02/28/2007 (PI)
Bristol-Myers Squibb

Differences in Baseline Patient Characteristics and Their Contribution to the Disparate Efficacy Conclusions of SPORTIF III and SPORTIF V
06/07/2005 - 12/06/2006 (PI)
AstraZeneca


Effectiveness and Safety of Antithrombotic Strategies after Joint Replacement
02/16/2011 - 01/31/2017 (PI)
NIH-NHLBI
5R01 HL106029-05

Effect of Statins and Modifiable Factors on Stroke Outcome in Atrial Fibrillation
09/30/2010 - 07/31/2015 (PI)
NIH-NINDS
5R01 NS070307-03

IPA Agreement - Guneet Jasuja
06/01/2013 - 08/31/2014 (PI)
VA

BRIDGE Trial
11/01/2009 - 10/31/2010 (PI)
Duke Clinical Research Inst NIH-NHLBI
U01 HL087229


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Wyn Davies D, Day JD, d''Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. J Interv Card Electrophysiol. 2017 Sep 15.View Related Profiles. PMID: 28914401.
  2. Melloni C, Dunning A, Granger CB, Thomas L, Khouri MG, Garcia DA, Hylek EM, Hanna M, Wallentin L, Gersh BJ, Douglas PS, Alexander JH, Lopes RD. Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial. Am J Med. 2017 Jul 21. PMID: 28739198.
  3. Pollack CV, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI. Idarucizumab for Dabigatran Reversal - Full Cohort Analysis. N Engl J Med. 2017 08 03; 377(5):431-441. PMID: 28693366.
  4. Melloni C, Shrader P, Carver J, Piccini JP, Thomas L, Fonarow GC, Ansell J, Gersh B, Go AS, Hylek E, Herling IM, Mahaffey KW, Yu AF, Peterson ED, Kowey PR. Management and outcomes of patients with atrial fibrillation and a history of cancer: the ORBIT-AF registry. Eur Heart J Qual Care Clin Outcomes. 2017 Jul 01; 3(3):192-197. PMID: 28838088.
  5. Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindbäck J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. J Am Heart Assoc. 2017 Jun 23; 6(6). PMID: 28645934.
  6. Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d''Avila A, Natasja de Groot NMS, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. TEMPORARY REMOVAL: 2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm. 2017 May 12.View Related Profiles. PMID: 28506916.
  7. Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Hylek E, Kowey PR, Mahaffey KW, O''Brien EC, Singer DE, Peterson ED, Piccini JP. Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). Am Heart J. 2017 Jul; 189:40-47. PMID: 28625380.
  8. Kapoor A, Ellis A, Shaffer N, Gurwitz J, Chandramohan A, Saulino J, Ishak A, Okubanjo T, Michota F, Hylek E, Trikalinos TA. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J Thromb Haemost. 2017 Feb; 15(2):284-294. PMID: 28102615; DOI: 10.1111/jth.13566;.
  9. Pandey A, Kim S, Moore C, Thomas L, Gersh B, Allen LA, Kowey PR, Mahaffey KW, Hylek E, Peterson ED, Piccini JP, Fonarow GC. Predictors and Prognostic Implications of Incident Heart Failure in Patients With Prevalent Atrial Fibrillation. JACC Heart Fail. 2017 Jan; 5(1):44-52. PMID: 28034376; DOI: 10.1016/j.jchf.2016.09.016;.
  10. Raimondi P, Hylek EM, Aronis KN. Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies. Curr Pharm Des. 2017; 23(9):1406-1423. PMID: 27917717.
Showing 10 of 208 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 208 publications over 24 distinct years, with a maximum of 30 publications in 2014

YearPublications
19921
19941
19951
19961
19981
19991
20003
20013
20021
20036
20043
20052
20066
200710
200815
200911
20108
201118
20129
201321
201430
201522
201624
201710
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Antithrombotic Therapy
Atrial Fibrillation
Intracranial Hemorrhage
Stroke
Thrombosis

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:


801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map


Hylek's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department